Cross reactivity of spike glycoprotein induced antibody against Delta and Omicron variants before and after third SARS-CoV-2 vaccine dose in healthy and immunocompromised individuals

Faustini, Sian, Shields, Adrian, Banham, Gemma, Wall, Nadezhda, Al-Taei, Saly, Tanner, Chloe, Ahmed, Zahra, Efstathiou, Elena, Townsend, Neal, Goodall, Margaret, Plant, Tim, Perez-Toledo, Marisol, Jasiulewicz, Aleksandra, Price, Ruth, McLaughlin, James, Farnan, John, Moore, Julie, Robertson, Louise, Nesbit, Andrew, Curry, Grace, Black, Amy, Cunningham, Adam, Harper, Lorraine, Moore, Tara, Drayson, Mark, Richter, Alex

Faustini, Sian, Shields, Adrian, Banham, Gemma, Wall, Nadezhda, Al-Taei, Saly, Tanner, Chloe, Ahmed, Zahra, Efstathiou, Elena, Townsend, Neal, Goodall, Margaret, Plant, Tim, Perez-Toledo, Marisol, Jasiulewicz, Aleksandra, Price, Ruth, McLaughlin, James, Farnan, John, Moore, Julie, Robertson, Louise, Nesbit, Andrew, Curry, Grace, Black, Amy, Cunningham, Adam, Harper, Lorraine, Moore, Tara, Drayson, Mark, Richter, Alex.

The Journal of infection ; 2022.

Artigo em Inglês | EuropePMC | ID: covidwho-1615130

Buscar no Google

Imprimir

XML

Coleções: Bases de dados de organismos internacionais Base de dados: EuropePMC Tipo de estudo: Estudo experimental / Ensaios controlados aleatorizados Tópicos: Vacinas / Variantes Idioma: Inglês Revista: The Journal of infection Ano de publicação: 2022 Tipo de documento: Artigo

Similares

MEDLINE

LILACS

LIS

Buscar no Google

Imprimir

XML